Biopharmaceutical Industry Collaborating to Better Control Raw Material Quality Through Improved Supply Chain Communications

The biopharmaceutical industry is working collaboratively to expand its ability to control the quality of the wide variety of raw materials that are being used in production and formulation through improved communications across the increasingly complex supply chains involved.

Marking the heightened biotech industry awareness of the pressing need to better understand and address the raw material control challenges it is facing are collaborative initiatives that have been launched recently by both the BioPhorum Operations Group (BPOG) and the European Biotechnology Enterprises (EBE) arm of the European Federation of Pharmaceutical Industry Associations (EFPIA).

At conferences held in late April and May, insights were provided on the drivers, scope, progress and goals of the initiatives by industry experts involved.

Robert Posgai, director of materials procurement in Biogen’s global supply chain organization, discussed the BPOG effort at the IPEC-Americas/ExcipientFest conference held in Baltimore, Maryland in late April.

A presentation was given on the EBE initiative by Annick Gervais, director of UCB‚Äôs physical-chemical method development in analytical sciences for biologics, at the ‚Äúsatellite session‚ÄĚ that the EBE‚Äôs BioManufacturing Working Group sponsored in conjunction with the CASSS biotech CMC Strategy Forum Europe, held in Paris in mid-May.

[CLICK HERE for the complete story.  Nonsubscribers can get information on IPQ subscriptions and licensing or individual story purchasing by contacting Jonathan Trethowan (]